You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 16, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
M K Baxi1, J Robertson, L A Babiuk
1Virology Group, Veterinary Infectious Diseases Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E3.
Researchers modified bovine adenovirus type 3 (BAV3) early region 4 (E4) to enhance its potential as a gene therapy and vaccination vector. Deleting specific E4 open reading frames (Orfs) did not hinder viral replication, increasing vector capacity for therapeutic gene delivery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: